Cargando…

Overcoming immunosuppression as a new immunotherapeutic approach against pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest types of malignancy. Via a broad stimulation of the immune system, PDAC activates both antitumor immune responses and immunosuppressive mechanisms. We propose that new immunotherapeutic strategies for the management of PDAC should be de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bazhin, Alexandr V, Bayry, Jagadeesh, Umansky, Viktor, Werner, Jens, Karakhanova, Svetlana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850017/ https://www.ncbi.nlm.nih.gov/pubmed/24327934 http://dx.doi.org/10.4161/onci.25736

Ejemplares similares

New strategies for melanoma immunotherapy: How to overcome immunosuppression in the tumor microenvironment
por: Umansky, Viktor
Publicado: (2012)

Regulatory T cells do not suppress rather activate human basophils by IL-3 and STAT5-dependent mechanisms
por: Das, Mrinmoy, et al.
Publicado: (2020)

Dendritic cells matured in the presence of TLR ligands overcome the immunosuppressive functions of regulatory T cells
por: Berk, Erik, et al.
Publicado: (2014)

MicroRNAs as novel immunotherapeutics
por: Heimberger, Amy B, et al.
Publicado: (2013)

Survivin the battle against immunosuppression
por: Manuel, Edwin R., et al.
Publicado: (2012)

An immunotherapeutic intervention against tumor progression: Targeting a driver of the epithelial-to-mesenchymal transition
por: Palena, Claudia, et al.
Publicado: (2014)

Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses
por: Shevchenko, Ivan, et al.
Publicado: (2020)

Immune mediated mechanisms of melanocyte destruction: Paving the way for efficient immunotherapeutic strategies against melanoma
por: Speeckaert, Reinhart, et al.
Publicado: (2012)

Immunotherapeutic implications of the immunophenotype of pediatric brain tumors
por: Griesinger, Andrea M, et al.
Publicado: (2014)

REG3β contributes to the immunosuppressive microenvironment of pancreatic cancer
por: Folch-Puy, Emma
Publicado: (2013)

Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells
por: Morello, Silvana, et al.
Publicado: (2014)

The fatal alliance of cancer and T cells: How pancreatic tumor cells gather immunosuppressive T cells
por: Grage-Griebenow, Evelin, et al.
Publicado: (2014)

Pancreatic cancer-associated stellate cells: A viable target for reducing immunosuppression in the tumor microenvironment
por: Mace, Thomas A, et al.
Publicado: (2013)

LTX-315 (Oncopore™): A short synthetic anticancer peptide and novel immunotherapeutic agent
por: Camilio, Ketil André, et al.
Publicado: (2014)

The dual targeting of immunosuppressive cells and oxidants promotes effector and memory T-cell functions against lung cancer
por: Sawant, Anandi, et al.
Publicado: (2014)

Overcoming resistance to immunotherapy by teaching old drugs new tricks
por: Perry, John M., et al.
Publicado: (2020)

Interferon-α Up-Regulates the Expression of PD-L1 Molecules on Immune Cells Through STAT3 and p38 Signaling
por: Bazhin, Alexandr V., et al.
Publicado: (2018)

The S100A8/A9 complex reduces CTLA4 expression by immature myeloid cells: Implications for pancreatic cancer-driven immunosuppression
por: Basso, Daniela, et al.
Publicado: (2013)

Thwarting galectin-induced immunosuppression in breast cancer
por: Salatino, Mariana, et al.
Publicado: (2013)

The role of soluble CD40L in immunosuppression
por: Schlom, Jeffrey, et al.
Publicado: (2013)

Disrupting the endothelin and Wnt relationship to overcome chemoresistance
por: Rosanò, Laura, et al.
Publicado: (2015)

Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy
por: Bazhin, Alexandr V., et al.
Publicado: (2018)

Hypoxia-driven immunosuppression contributes to the pre-metastatic niche
por: Sceneay, Jaclyn, et al.
Publicado: (2013)

Interleukin-27 tackles immunosuppression in chronic lymphocytic leukemia
por: Fernandez Botana, Iria, et al.
Publicado: (2023)

Non-replicating Toxoplasma gondii reverses tumor-associated immunosuppression
por: Fox, Barbara A, et al.
Publicado: (2013)

Blockade of PD-1 immunosuppression boosts CAR T-cell therapy
por: John, Liza B, et al.
Publicado: (2013)

Forging a link between oncogenic signaling and immunosuppression in melanoma
por: Khalili, Jahan S., et al.
Publicado: (2013)

Influence of Interferon-Alpha Combined with Chemo (Radio) Therapy on Immunological Parameters in Pancreatic Adenocarcinoma
por: Karakhanova, Svetlana, et al.
Publicado: (2014)

Immuno-targeting of pancreatic cancer stem cells: A new therapeutic strategy against a devastating disease?
por: Cioffi, Michele, et al.
Publicado: (2012)

‘Hardcore’ OX40(+) immunosuppressive regulatory T cells in hepatic cirrhosis and cancer
por: Piconese, Silvia, et al.
Publicado: (2014)

Contribution of regulatory T cells to immunosuppression and disease progression in multiple myeloma patients
por: Raja, Karthick Raja Muthu, et al.
Publicado: (2013)

Autoimmune and inflammatory diseases following COVID-19
por: Galeotti, Caroline, et al.
Publicado: (2020)

High risk of autoimmune diseases after COVID-19
por: Sharma, Chetan, et al.
Publicado: (2023)

Reactive Oxygen Species in Cancer Biology and Anticancer Therapy
por: Bazhin, Alexandr V., et al.
Publicado: (2016)

Sugars boost exhausted tumor-infiltrating lymphocytes by counteracting immunosuppressive activities of galectins
por: Gordon-Alonso, Monica, et al.
Publicado: (2014)

High-affinity peptide-based anticancer vaccination to overcome resistance to immunostimulatory antibodies
por: Binder, David C, et al.
Publicado: (2013)

High immunosuppressive burden in advanced hepatocellular carcinoma patients: Can effector functions be restored?
por: Lugade, Amit A, et al.
Publicado: (2013)

Overcoming HLA restriction in clinical trials: Immune monitoring of mRNA-loaded DC therapy
por: Van Nuffel, An M.T., et al.
Publicado: (2012)

The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors
por: Bellone, Matteo, et al.
Publicado: (2013)

T-cell suppression mediated by regulatory T cells infiltrating hepatic tumors can be overcome by GITRL treatment
por: Pedroza-Gonzalez, Alexander, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cbnlqtfq5tl72570u57anpk421